Brief: Travere Therapeutics Entered Amended & Restated Agreement Of Upto $100 Million In Common Stock Offering
31/10/2024 13:15
Oct 31 (Reuters) - Travere Therapeutics Inc TVTX.O :
* TRAVERE THERAPEUTICS: ENTERED AMENDED & RESTATED
AGREEMENT OF
UPTO $100 MILLION IN COMMON STOCK OFFERING
Source text: ID:n0001438533-24-000050
Further company coverage: TVTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Travere Therapeutics
See all newsBrief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics - Receives USPTO Notice Of Allowance For Filspari Patent In FSGS
Brief: Travere Therapeutics Announces Planned Chief Executive Officer Transition
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule